# Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)

> **NCT03603912** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Mina Chung, MD** · enrollment: 175 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Metformin
- **BEHAVIORAL:** Lifestyle/Risk Factor Modification

## Key facts

- **NCT ID:** NCT03603912
- **Lead sponsor:** Mina Chung, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-08-24
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03603912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03603912, "Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03603912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*